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Abstract: Aim: Endodontic infections are caused by the invasion of various microorganisms
into the root canal system. Candida albicans is a biofilm forming yeast and the most prevalent
eukaryotic microorganism in endodontic infections. In this study we investigated the ability of
C. albicans to tolerate treatment with standard endodontic irrigants NaOCl (sodium hypochlorite),
ethylenediaminetetraacetic acid (EDTA) and a combination thereof. We hypothesized that biofilm
formed from a panel of clinical isolates differentially tolerate disinfectant regimens, and this may have
implications for secondary endodontic infections. Methodology: Mature C. albicans biofilms were
formed from 30 laboratory and oral clinical isolates and treated with either 3% NaOCl, 17% EDTA or
a sequential treatment of 3% NaOCl followed by 17% EDTA for 5 min. Biofilms were then washed,
media replenished and cells reincubated for an additional 24, 48 and 72 h at 37 ◦C. Regrowth was
quantified using metabolic reduction, electrical impedance, biofilm biomass and microscopy at 0,
24, 48 and 72 h. Results: Microscopic analysis and viability readings revealed a significant initial
killing effect by NaOCl, followed by a time dependent significant regrowth of C. albicans, but with
inter-strain variability. In contrast to NaOCl, there was a continuous reduction in viability after
EDTA treatment. Moreover, EDTA significantly inhibited regrowth after NaOCl treatment, though
viable cells were still observed. Conclusions: Our results indicate that different C. albicans biofilm
phenotypes grown in a non-complex surface topography have the potential to differentially tolerate
standard endodontic irrigation protocols. This is the first study to report a strain dependent impact
on efficacy of endodontic irrigants. Its suggested that within the complex topography of the root
canal, a more difficult antimicrobial challenge, that existing endodontic irrigant regimens permit cells
to regrow and drive secondary infections.
Keywords: biofilm; Candida albicans; EDTA; NaOCl; tolerance
1. Introduction
Fungal infections are generally perceived as being relatively uncommon, yet are reported to affect
more than a billion people [1]. This is exacerbated when we consider the alarming global burden
of antifungal resistance that we now experience [2]. Many infections we believe to be of bacterial
origin are in fact fungal. Indeed, the yeast Candida albicans is a ubiquitous human commensal, but with
opportunistic tendencies. Its capacity to morphologically transition from yeast to hyphal cells enables
it to react dynamically, both in evasion of host immunity and in its ability to readily form biofilm
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structures that impact increased antifungal resistance [3]. C. albicans frequently resides in the oral
cavity as a biofilm forming microorganism, interacting with other oral microbiota and the host. When
we consider root canal infections, pathogenic yeasts have also been isolated from teeth associated with
primary apical periodontitis and post-treatment disease [4].
Dental pulp is generally a sterile tissue containing nerves and vascular tissues that are connected
to the surrounding periradicular tissues, though recent studies appear to suggest the presence of
bacterial DNA in the pulp of pristine healthy teeth [5]. The pulp is protected from the oral microbiome
by layers of mineralised tissues (dentin, enamel and cementum). Breach to these tissues, as a result of
dental caries, tooth fractures or cracks, can expose the dentin and provide routes for oral microbiota to
ingress towards the pulp [6]. Another route of pulp infection is the direct invasion of microorganisms
to the pulp during root canal treatment during substandard clinical procedures. C. albicans is the
most frequently isolated species in endodontic infections [7,8]. The prevalence of yeast in persistent
infections is higher than that in primary infections [4]. However, two recent systematic reviews
found that C. albicans prevalence does vary significantly between primary and secondary endodontic
infections [7,8]. In this environment C. albicans can colonise dentinal walls and penetrate into dentinal
tubules [9,10]. The route of fungal invasion to the root canals is likely to be through cracks or via
leaking restoration, though the diameter of hyphae, which is 1.9–2.6 µm [11], cannot exclude the
possibility of dentinal tubules invasion especially in deep caries lesions. Here, candida yeasts are
capable of coalescing with one another in the form of biofilm, which is a multicellular community of
yeast and hyphal forms encased in polymeric glue. The biofilm lifestyle enhances the ability of the
cells to withstand host and antifungal factors, ultimately contributing to its persistence within the root
canal. This phenotype, along with the complexity of root canal system, particularly in the apical third
of root canals, are thought to be the major causes of treatment-resistant apical periodontitis.
Root canal treatment (RCT) is the treatment of choice for these endodontic infections. RCT aims
to: (1) eliminate microorganisms from the root canal system to a level that promotes the healing
of periradicular tissues, and (2) provide a three-dimensional hermetic seal to prevent reinfection.
Different hand and rotary instruments are used during RCT in order to mechanically debride the
biofilm on the root canal walls. Nevertheless, the cross-sectional root canal configuration can pose
a challenge to adequate debridement, as these instruments tend to leave untouched recesses in oval
canals [12,13]. This instrumentation can however create a smear layer that covers the root canal walls,
which consists of organic (pulp tissue remnants) and inorganic (dentin chips) tissues [14]. This layer
might act as a protective barrier to encase biofilms formed on root canal walls [15] and might also
encourage the adherence of microorganisms, such as C. albicans [16]. Furthermore, it may compromise
the quality of root canal sealing [17]. Therefore, the use of chemical irrigating solutions to maximise
root canal debridement and removal of the smear layer is vital for successful RCT, which includes
ethylenediaminetetraacetic acid (EDTA), though not universally [18]. EDTA acts mainly as an adjunct
irrigant to remove smear layer, though an alternative effect is the inhibition of filamentation through
chelation of necessary divalent cations in the pathogenic yeast C. albicans [19], a structural element
strongly associated with robust biofilm formation.
Recent work from our group has highlighted the clinical relevance of biofilm heterogeneity
between isolates of C. albicans from the oral cavity and other clinical sites [20]. The overriding message
from this review is that with respect to particular groups of microorganisms, they cannot all be
considered as a single entity and “one size does not fit all” when it comes to treatment regimens.
We have shown that the greater capacity to form biofilm is linked to enhanced virulence and increased
resistance to antifungals [21]. Further studies of this yeast, alongside the emerging yeast pathogen C.
auris, have demonstrated that biofilm-mediated patterns of resistance also exist for both antiseptics
and disinfectants, including sodium hypochlorite [22]. Given that sodium hypochlorite (NaOCl) and
EDTA are principal components of the management of endodontic infections [23], we hypothesised
that root canal treatment failure involving C. albicans may be driven by biofilm heterogeneity resulting
Antibiotics 2019, 8, 204 3 of 13
in an enhanced ability to withstand treatment and regrow within root canals. We therefore aimed to
assess how different biofilm phenotypes responded in vitro to NaOCl and EDTA treatments.
2. Material and Methods
2.1. Microbial Growth Conditions and Standardisation
C. albicans laboratory strains SC5314 [24] and 3153A [25], and 28 clinical isolates obtained from an
oral rinse from patients attending restorative clinics at Glasgow Dental Hospital and School for routine
dental care, as previously described [26]. Antifungal susceptibility profiles and proteolytic activity of
these strains have been described previously [27,28]. Notably, these studies showed that these isolates
(saliva derived) were highly sensitive planktonically to azoles, polyenes and echinocandins, whereas in
sessile mode they were resistant to only azoles [28]. Moreover, proteolytic assessment of these isolates
showed that those of a higher biofilm forming capacity were more proteolytic [27]. The strains were
subcultured on Sabouraud’s dextrose agar [SAB (Sigma–Aldrich, Dorset, UK)] plates and maintained at
30 ◦C for 48 hours. An overnight culture was prepared in yeast peptone dextrose (YPD (Sigma-Aldrich,
Dorset, UK)) and incubated at 30 ◦C at 120 rpm in an orbital shaker (IKA KS 4000 i control, Berlin,
Germany). After 18 h, the yeast cells were pelleted by centrifugation, washed twice with phosphate
buffered saline (PBS (Sigma–Aldrich, Dorset, UK)) and counted using a haemocytometer.
2.2. Biofilm Development and Biofilm Forming Ability Characterisation
C. albicans strains were standardised to the desired cellular density of 1 × 106 cells/mL into Roswell
Park Memorial Institute (RPMI)-1640 (Sigma–Aldrich, Dorset, UK) medium and the biofilms formed
onto pre-sterilised, polystyrene, 96-well flat-bottom microtiter plates (Corning Incorporated, Corning,
NY, USA) as previously described [29]. The plates were incubated at 37 ◦C for 24 h. After incubation,
the biofilms were washed with PBS to remove the loosely attached cells and the biofilm biomass of all
strains was quantified using the crystal violet (CV) assay, as previously described [30]. The biomass
was then quantified spectrophotometrically by reading absorbance at 570 nm using microtiter plate
reader (FLUOStar Omega, BMG Labtech, Aylesbury, UK).
The growth profiles of the selected test strains were also assessed using an xCELLigence system
(ACEA, Biosciences Inc., San Diego, California, USA). Briefly, this system is a real-time cell analysis
instrument that uses patented microtitre plates (E-plates®) that contain gold biosensors embedded
in the bottom of each well. Quantifiable data was expressed as cell index, which represents the
cell impedance when the cells adhere, or associated matrix, to the electrodes [31]. These biosensors
continuously and non-invasively monitor changes in cell number, cell size, cell-substrate attachment
quality, and extrapolymeric substance (EPS) production. C. albicans (1 × 106 cells/mL) in RPMI-1640
was seeded into 96-well E-plates® (ACEA, Biosciences Inc.) and the plates incubated for 24 h at 37 ◦C
with readings taken every 30 min.
2.3. Planktonic Minimum Inhibitory Concentration (MIC)
MIC was determined using a broth microdilution method according to the M27-A3 standard for
fungi [32] (CLSI). Briefly, cells were adjusted to the desired density of 2 × 104 cells/mL in Roswell
Park Memorial Institute (RPMI) media (Sigma–Aldrich, Dorset, UK). A series of two-fold dilutions
of 3% (30,000 ppm) NaOCl (Parcan; Septodont, Saint-Maur-des-Fosses, France) and 17% (EDTA
[ENDO-SOLution, Stalowa Wola, Poland]) were performed using 96-well round-bottom microtiter
plates (Corning Incorporated, Corning, NY, USA). The plates were at 37 ◦C. After 24 h, the MIC
concentration was determined as the lowest concentration that prevents visible growth.
2.4. Biofilm Treatment and Regrowth Assessment
After biofilm growth, they were washed with PBS and treated with 3% NaOCl, 17% EDTA for
5 min, or sequentially treated with NaOCl followed by EDTA for 5 min each. Untreated controls
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were used for comparison. The effect of NaOCl was deactivated with 5% sodium thiosulfate for
10 min (Fisher Chemicals, London, UK) and EDTA was deactivated using Dey Engley Neutralising
broth (Sigma-Aldrich, London, UK) for 15 min. Sodium thiosulfate and Dey Engley Neutralising
broth were also applied to untreated controls to normalise results. The viability of the biofilms was
quantified immediately after treatment using XTT metabolic activity assay (Sigma-Aldrich, UK) and
CV as described above. The absorbance was measured spectrofluorometrically using a plate reader
(FLUOStar Omega, BMG Labtech, Aylesbury, UK) at a wavelength of 490 nm for XTT and 570 nm for
CV according to the manufacturer’s recommendation. To further explore the effect of this treatment,
post-treatment, the microtitre plates were washed with PBS and fresh RPMI-1640 media replenished.
The plates were re-incubated at 37 ◦C for 24, 48 and 72 h and XTT viability and CV assessment
performed, as described above. To validate this approach, we mirrored this experimental procedure
using the xCELLigence system. Instead of static endpoint measurements, we were able to monitor
biofilm regrowth in real-time. Briefly, following the initial treatment, deactivation and washing steps,
the wells were replaced with RPMI and the entire plate sonicated for 5 min to remove retained adherent
biofilm cells. The sonicated cells were then transferred into 96-well plastic E-plates, and the plates
re-incubated at 37 ◦C for 72 h, with cell impedance quantified every 30 min. In parallel, plates were
imaged using EVOS FL Cell Imaging system (Thermo Fisher Scientific, Waltham, MA, USA).
2.5. Statistical Analysis
Viability and biomass data of C. albicans BC023 and BC146 were chosen to represent the low
biofilm forming (LBF) and high biofilm forming (HBF) strains respectively. GraphPad Prism (version
7.0 d) was used for creating graphs and statistical analysis. Data was tested for normal distribution
using D’Agostino-pearson omnibus normality test and were plotted as log were required. Student t-test
was used to compare LBH and HBF viability. One-way ANOVA with Tukey’s multiple comparison
test was used to statistically compare biofilm viability after NaOCl treatment for each isolate over
time while A Kruskal–Wallis test with Dunn’s multiple comparison test was used to compare viability
following the three treatment conditions.
3. Results
3.1. Oral Candida albicans differentially form biofilms and are NaOCl sensitive
Initially, biofilm biomass was assessed for the 28 C. albicans clinical isolates (Figure 1). Isolates
showed different biofilm forming abilities with the biofilm biomass for 18 isolates ranges between
0.4–1.0 mean optical density. The five lowest biofilm forming isolates (LBFs) and the five highest
biofilm formers (HBFs) were subsequently selected to test their susceptibility to NaOCl and EDTA
treatment. In terms of growth profiles, BC023 (the lowest biofilm forming clinical isolate), BC146 (the
highest biofilm forming clinical isolate), 3153A (low biofilm forming laboratory strain) and SC5314
(high biofilm forming laboratory strain) were used as controls. Growth profiles of BC023 and 3153A
(Figure 2a) were clearly different from those of BC146 and SC5314 (Figure 2b). LBFs showed less
irregularities before both reach saturation phase when the E-plate electrodes become entirely covered
with Candida cells. This difference suggests the potential of xCELLigence system to differentiate LBF
and HBF isolates based on their growth profiles. NaOCl MIC for all LBFs and HBFs was 0.093%
(930 ppm) and 0.13% for EDTA.
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Figure 1. Quantification of biofilm biomass from clinical isolates. low biofilm forming (LBF) and high
biofilm forming (HBF) identified by horizontal lower and higher dotted lines. Those isolates with an
open circle or half dark/white circle represent the five LBF and HBF isolates selected for downstream
analysis, respectively.
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Figure 2. Growth profile as shown by xCELLigence system. Data represent the mean of normalized
cell index values taken every 30 min over 24 h of (a) C. albicans 3153A and five LBFs (b) C. albicans
SC5314 and five HBFs.
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3.2. Oral Candida albicans persistsfFollowing NaOCl treatment
Following NaOCl application, cell viability expressed in percentage in relation to untreated
controls was assessed (Figure 3). In spite of the initial killing effect of NaOCl (78.7%, 98.3% reduction
in viability for LBF and HBF, respectively), both isolates were able to regrow over time. LBF and
HBF showed comparable regrowth profiles. However, LBF revealed higher immediate post-treatment
viability compared to HBF (p < 0.05). In terms of post-treatment regrowth, the viability increased
significantly between 0 and 72 h for both LBF (p < 0.0001) and HBF (p < 0.01) with maximum viability
at 48 h (p < 0.0001). No significant difference was observed between viability at 48 and 72 h for both
isolates. Data from xCELLigence system confirm the above-mentioned results for HBF (Figure 4b), but
not for LBF (Figure 4a).
Figure 3
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Figure 3. Viability percentage of biofilms in relation to untreated biofilms after treatment with NaOCl
and reincubation with fresh Roswell Park Memorial Institute (RPMI) media. Immediate post-treatment
(0), 24, 48 and 72 h for LBF (upper line) and HBF (lower line). Values represent the mean with standard
error of the mean (SEM) from three independent experiments.
Figure 4
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Figure 4. Regrowth from 0 to 72 h as detected by xCELLigence system and presented as normalized
cell index for (a) five LBF (b) five HBF.
3.3. Oral Candida albicans regrowth after NaOCl treatment is significantly inhibited by EDTA
As showed in the previous data, C. albicans persist following NaOCl treatment and have the
potential to regrow. In terms of EDTA treatment, the metabolic activity of LBF (Figure 5a) and HBF
(Figure 5b) was initially decreased by 82%, 97%, respectively, when compared to untreated biofilms.
Again, LBF showed significantly higher immediate post-treatment tolerance to EDTA than HBF
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(p < 0.001). In contrast to NaOCl, the metabolic activity following EDTA treatment showed a continued
reduction between 0 and 72 h for both isolates. Similar trends were observed for NaOCl + EDTA
treatment of LBF, but not for HBF. The metabolic activity is significantly lower in EDTA and NaOCl +
EDTA in comparison to NaOCl alone for both isolates at 48 (p < 0.0001) and 72 h (p < 0.05, p < 0.01 for
LBF and p < 0.0001 for HBF). Finally, there was not a significant difference between EDTA and NaOCl
+ EDTA at all time points.Figure 5
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Figure 5. The effect of the three treatment conditions: NaOCl, ethylenediaminetetraacetic acid (EDTA)
and NaOCl + EDTA on pre-formed 24 h biofilms viability in relation to untreated biofilms. Biofilms
were treated for 5 min and reincubated with fresh RPMI. XTT readings were taken at 0, 24, 48 72 h.
Values were plotted as log10 on the Y axis. (a) absorbance values for LBF (b) absorbance values for
HBF. Statistical significance between the three treatment conditions at 48, and 72 h was presented as
* p < 0.05, ** p < 0.01 and **** p < 0.0001. Whereas the significant difference in relation to untreated
biofilms of the same treatment condition over time was presented as # p < 0.05, ## p < 0.01, ### p < 0.001
and #### p < 0.0001.
Increased viability over time with NaOCl treated biofilms was not matched with an increase in
biofilm biomass for both isolates. Furthermore, EDTA treated HBF shows significantly higher biomass
in comparison to NaOCl and NaOCl + EDTA at all time points (Figure 6b). At 72 h, NaOCl + EDTA is
not superior in decreasing biofilm biomass compared to NaOCl alone for HBF, but it is more effective
in decreasing biomass compared with NaOCl treatment in LBF (p < 0.001) (Figure 6a).Figure 6
0h 24h 48h 72h
0.001
0.01
0.1
1
10
Time (Hours)
B
io
m
as
s 
(O
D
57
0 
nm
)
NaOCl 
EDTA 
NaOCl+EDTA 
Untreated(a)
#
#
# #  # #
# #
# #
#
# # # #
# # # #
* * *
0h 24h 48h 72h
0.001
0.01
0.1
1
10
Time (Hours)
B
io
m
as
s 
(O
D
57
0 
nm
)
(b)
# 
# # # #
# # 
# # 
# 
# # 
# 
* *
* * * *
Figure 6. The effect of the three treatment conditions: NaOCl, EDTA and NaOCl + EDTA on pre-formed
24 h biofilms biomass in relation to untreated biofilms. Crystal violet (CV) readings were taken
at 0, 24, 48 and 72 h. Values were plotted as log10 on the Y axis. (a) Biofilm biomass for LBF (b)
Biofilm biomass for HBF. Statistical significance between the three treatment conditions at 72 h was
presented as ** p < 0.01, *** p < 0.001 and **** p < 0.0001. Whereas the significant difference in relation
to untreated biofilms of the same treatment condition over time was presented as # p < 0.05, ## p < 0.01
and #### p < 0.0001.
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Microscopic examination is consistent with these data (Figure 7). There are visibly evident cells
for both isolates at 0 h in the all treatment conditions (Figure 7a,b). However, the visible quantity of
cells increased significantly over time in NaOCl treated biofilms for both isolates. In EDTA treatment,
the number of cells remained relatively stable over time in both isolates, with maintaining biofilm
architecture in HBF. Finally, NaOCl + EDTA showed significantly less cells at 24, 48 and 72 h compared
with NaOCl alone and EDTA alone. Antibiotics 2019, 8, x 8 of 13 
 
 
Figure 7. Microscopic examination of biofilms at four conditions: untreated, NaOCl, EDTA and 
NaOCl + EDTA treated biofilms. It demonstrates the biofilms at four time points, 0, 24, 48 and 72 h. 
(a) LBF (b) HBF. Bar is 40 µM for all panels. 
4. Discussion 
C. albicans biofilm infections are heterogeneous, and it has been shown that depending on the 
phenotype of a specific clinical isolate, this may have a profound impact on patient outcomes [33]. 
Therefore, we sought to test whether these characteristics played a role in a dentally relevant scenario. 
Root canal treatment is the treatment of choice for endodontic infections. The use of chemical 
irrigating solutions to disinfect the root canal and to remove the smear layer is vital for success. An 
Figure 7. Microscopic examination f biofilms at four conditions: untreated, NaOCl, EDTA and NaOCl
+ EDTA treated biofilms. It demonstrates the biofilms at four time points, 0, 24, 48 and 72 h. (a) LBF (b)
HBF. Bar is 40 µM for all panels.
Antibiotics 2019, 8, 204 9 of 13
4. Discussion
C. albicans biofilm infections are heterogeneous, and it has been shown that depending on the
phenotype of a specific clinical isolate, this may have a profound impact on patient outcomes [33].
Therefore, we sought to test whether these characteristics played a role in a dentally relevant scenario.
Root canal treatment is the treatment of choice for endodontic infections. The use of chemical irrigating
solutions to disinfect the root canal and to remove the smear layer is vital for success. An ideal irrigant
should provide a flushing action, have a broad spectrum antimicrobial activity, be able to inactivate
bacterial endotoxins, have the ability to dissolve the necrotic organic tissues, remove the smear layer,
have no adverse effect on dentin and be biocompatible with the periradicular tissues [34]. However, no
single irrigant possesses all of these characteristics. Here we modelled the in vitro ability of standard
endodontic irrigants to manage C. albicans biofilms, demonstrating a flaw in the capacity of NaOCl and
EDTA to effectively eradicate the biofilm.
The present study has demonstrated a significant variation between candidal phenotypes, with
LBF (mainly yeasts) and HBF (hyphal forms) differing in their susceptibility to NaOCl and EDTA.
Although HBF would be expected to show higher resistance to these irrigants attributed to its higher
biofilm forming ability, LBF showed greater tolerance in comparison to untreated control than HBF,
possibly due to the capacity of budding yeast cells to disperse. Radcliffe et al (2004) previously
examined the resistance of two strains of C. albicans to NaOCl of concentrations ranges from 0.5% to
5.25% and found that NaOCl as low as 0.5% lowered the colony forming units (CFU) to below the
detection limit for the tested strains [35]. No difference was noted between the response of the tested
strains. However, this study examined treatment of planktonic cells rather than biofilm. As highlighted
previously, it is becoming clear that the heterogeneity of microbial isolates requires attention when
considering treatment strategies, it is no longer appropriate to assume that because a protocol is
effective for one clinical isolate that it will be equally effective for another. We are now in the era of
personalised antimicrobial therapy; although this may not be directly relevant in endodontic treatment,
it does highlight the potential need for fine tuning of irrigation protocols that can take into account
differential sensitivities.
In an attempt to enhance the sensitivity of the analysis, we employed an xCELLigence system that
relies on electric impedance. Not previously used in either fungal or endodontic studies, the system
provided the potential to detect early phases of regrowth. It allowed determination of biofilm growth
kinetics in untreated samples, however, was less informative following NaOCl treatment. Due to the
degradation of the gold electrodes used in the E-plates, it was necessary to grow and treat biofilms in
conventional polystyrene, 96-well flat- bottom microtiter plates then sonicate and transfer the persistent
cells to xCELLigence system E-plates. There is a possibility that cells were lost during sonication or
transfer which may account for the poorly detectable regrowth in some LBF strains. Nonetheless, the
novelty of this real-time biofilm monitoring system enabled us to assess biofilm regrowth in real-time
for several of these treated isolates.
NaOCl is the most widely used endodontic irrigant due its potent and wide spectrum antimicrobial
properties and organic tissue dissolving ability, although it may be associated with several risks such as
tissue toxicity, emphysema, allergy and undesirable taste and smell [36]. Various studies investigated
the effect of different NaOCl concentrations on C. albicans at a variety of clinically relevant treatment
time points and concentrations. Previously, it was shown that NaOCl has the highest efficacy against
C. albicans [37]. They showed that NaOCl (0.5% and 5%) completely killed all C. albicans cells in 30 sec,
with all the tested C. albicans strains showing similar susceptibility. However, our results show that
with 3% NaOCl application for 5 min on biofilms, some C. albicans cells were still viable and are able to
regrow. Waltimo et al (1999) tested the NaOCl against planktonic Candida cells, whereas 24 h biofilm
was used in the present study which may explain the different results [37]. This is particularly true
when considering that biofilms are believed to be significantly more tolerant to antimicrobials than
planktonic free cells [38,39]. Given the nature of endodontic infections that develop over a period of
time, and the fact that C. albicans has a great affinity for the collagen of the dentine which promotes
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yeast adhesion [10], it is more likely that C. albicans will occur in a biofilm rather than planktonic cells
in endodontic infections.
Recently, similar findings to our results were reported, where viable candidal cells were retrieved
from root canals following 3% treatment and incubation with growth media for 72 h [40]. However,
they tested the effect of NaOCl on C. albicans grown in root canals of previously healthy teeth, therefore,
it is more likely that viable cells would be retrieved due to the complexity and topography of root
canals and the presence of smear layer which may impede the action of NaOCl. Whereas, in the present
study biofilms were grown and treated on an uncomplicated 96-well flat-bottom microtitre plate. It is
widely believed that persistence of endodontic infections is mainly due to complexity of root canal
anatomy which impedes the disinfection of inaccessible areas [12,13]. In addition, the buffering action
of dentine and the small volume of irrigant within root canals are believed to decrease the killing
efficiency of NaOCl [41,42]. However, our results challenge this concept. We were able to demonstrate
that even though C. albicans biofilms were entirely exposed to a large volume of NaOCl in the absence
of dentine buffering effect, eradication of cells was unachievable.
EDTA is recommended as a part of endodontic irrigation protocols. Its main action is to remove the
smear layer to enhance the penetration of other irrigants due to its chelating action (it chelates calcium
ions from inorganic tissues). EDTA was reported, by many studies, to have a high antifungal efficacy
at concentration as low as 0.625 mg/L [43]. They suggest that EDTA antifungal activity is attributed to
its ability to decrease the metabolic activity by extracting calcium ions from C. albicans cell wall and the
medium and its anti-colonization action by reducing adhesion properties of C. albicans. Calcium ions
have a crucial role on the morphogenesis and pathogenesis of C. albicans by affecting adherence and
growth [19]. Interestingly, the metabolic activity of EDTA treated HBF was significantly lower while
the biofilm biomass of the same biofilms was significantly higher in comparison to untreated biofilms.
Furthermore, biofilm architecture of the same biofilms was maintained when viewed microscopically.
EDTA inhibits the metabolic activity of Candida cells, which may explain the low XTT readings while
maintaining high biomass. Previous research reported that EDTA inhibits biofilm formation of C.
albicans, but minimally affects pre-formed biofilms [19]. It was also reported that growth and biofilm
formation can be restored if EDTA is removed and fresh media is added. However, our present findings
showed a significant reduction in viability of EDTA treated pre-formed biofilms. Furthermore, there
was a continuous reduction in viability over time rather than regrowth. This variation can be explained
by the significant difference in EDTA concentration. A clinically relevant EDTA concentration of 17%
(equivalent to 581 mM) was used in this study, whereas the highest EDTA concentration used by
Ramage and colleagues was 250 mM [19].
Contrary to the results at our baseline time point, Sen and colleagues (2000) showed that EDTA
was superior to NaOCl in its antifungal effect [43]. In our study, there was no difference between the
two disinfectants on LBF, but there was a higher antifungal effect observed with NaOCl on HBF. This
group also used agar diffusion tests to compare the two, whilst we used biofilms and the XTT reduction
assay to assess antifungal activity which may account for the difference in the results [9]. Our findings
highlight the importance of including EDTA in irrigation protocols not only for smear layer removal,
but also for its antifungal properties and its ability to inhibit candidal regrowth after treatment with
NaOCl. It is important to note that our studies did not explore the effect of irrigant activation, which
is an integral part of endodontic disinfection protocols and could potentially, in combination with
NaOCl and EDTA, eliminate C. albicans and prevent its regrowth. Furthermore, C. albicans coexist with
multiple species and are known for their ability to form biofilms with and without other bacterial
species (mono-microbial and poly-microbial biofilms), such as Enterococcus faecalis and Staphylococcus
aureus [44]. As a result, future investigation should explore whether interkingdom interactions of C.
albicans with bacteria could complicate root canal treatment and provide protection to one another
ultimately leading to persistence.
In conclusion, C. albicans clinical isolates have variable biofilm forming abilities, which differentially
tolerate endodontic irrigants. These isolates were able to persist after 3% NaOCl treatment and regrow
Antibiotics 2019, 8, 204 11 of 13
to levels that are comparable with untreated biofilms, with more regrowth potential observed for yeast
cell phenotypes. EDTA significantly inhibits the persistence of NaOCl treated biofilms, though not
entirely, indicating possibilities for secondary endodontic infections.
5. Conclusions
This first of its kind study reports a strain dependent impact on efficacy of endodontic irrigants.
The in vitro data suggests that existing endodontic irrigant regimens are not 100% efficient, and
that biofilm tolerant cells are permitted to repopulate their immediate physical surroundings. The
clinical implications for these observations is the potential for a secondary infections driven by initial
ineffectual endodontic treatment. Clinicians conducting endodontic therapies should be aware of this
microbiological phenomenon, and support the development of alternative augmentative treatments.
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